Organ donor or graft pretreatment to prolong allograft survival: Lessons learned in the murine model

Transplantation

Volumn 69, Issue 11, 2000, Pages 2432-2439

  Pollak, Raymond ^a   Blanchard, Jacqueline M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; BETA 2 MICROGLOBULIN; CELL ADHESION MOLECULE; COMPLEMENT; CYCLOSPORIN A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IA ANTIBODY; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; RICIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HAPLOTYPE; HEART TRANSPLANTATION; IMMUNOGENICITY; IMMUNOMODULATION; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

EID: 0034660554     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200006150-00038     Document Type: Article

References (38)

1. Posselt AM, Barker CF, Tomaszewski JE, Markmann JF, Choti MA, Naji A. Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science 1990; 240: 1293
2. Holloran PF, Broski AP, Batuik TD, Madrenas J. The molecular immunology of acute rejection: an overview. Transplant Immunol 1993; 1: 3
3. Steinman RM, Kaplan G, Witmer MD, Conn ZA. Identification of a novel cell type in peripheral lymphoid organs in mice v. purification of spleen dendritic cells, new surface markers, and maintenance in vitro. J Exp Med 1979; 149: 1
4. Hart DNJ, Fabre JW. Demonstration and characterization of Ia positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain. J Exp Med 1981; 154: 347
5. Spriger TA. Adhesion receptors of the immune system. Nature 1990; 346: 425
6. Larsen CP, Morris PJ, Austyn JM. Migration of dendritic leukocytes from cardiac allografts into host spleens: a novel pathway for initiation of rejection. J Exp Med 1990; 171: 307
7. Steinman RM. The dendritic cell system and it's role in immunogenicity. Annu Rev Immunol 1991; 9: 271
8. Starzl TE, Demetris AJ, Murase N, Ilstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 1992; 2: 1579
9. Starzl TE, Trucco M, Zeevi. Systematic chimerism in human female recipients of male livers. Lancet 1992; 2: 876
10. Starzl TE, Demetris AJ, Trucco M. Chimerism after liver transplantation for type IV glycogen storage disease and type I Gaucher's disease. N Engl J Med 1993; 328: 745
11. Auchincloss H, Lee R, Shea S, Markowitz JS, Grusby MJ, Glimcher LH. The role of indirect recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci 1993; 90: 3373.
12. Shoskes DA, Wood KJ. Indirect presentation of MHC antigens in transplantation. Immunol Today 1994; 15: 32.
13. Lafferty KJ, Bootes A, Dart G, Talmage DW. Effect of organ culture on the survival of thyroid allografts in mice. Transplantation 1976; 22: 138.
14. Faustman D, Hauptfeld V, Lacy P, Davie J. Prolongation of murine islet allograft survival by pretreatment of islets with antibody directed to Ia determinants. Proc Natl Acad Sci 1981; 78: 5156.
15. Pollak R, Blanchard JM, Mozes MF. Strategies used to alter the immunogenicity of vascularized organ allografts prior to transplantation. Transplant Proc 1987; 19: 258.
16. Pollak R, Lee MF, Chang CW, Blanchard JM, Lazda VA, Mozes MF. Pretreatment of vascularized organ allografts with a Daunomycin-antibody conjugate to alter allograft immunogenicity. Transplant Proc 1988; 20(Suppl 1): 311.
17. Lloyd DM, Franklin W, Buckingham F, et al. Ex-vivo perfusion of the intact rat pancreas with anti-class II monoclonal antibody: labelling of dendritic cells. Transplant Proc 1987; 19: 620.
18. North J. In: Mishell BB and Shiigi SM, eds. Selected methods in cellular immunology. San Francisco: WH Freeman and Company, 1980; 273.
19. Goff DA, Carrol SF. Substituted 2-iinothiolanes: reagents for the preparation of disulfide crosslinked conjugates with increased stability. Bioconjug Chem 1990; 1: 381.
20. T 30,000 form of Ricin A chain. Cancer Res 1991; 51: 4219.
21. Thorpe PE, Wallace PM, Knowles PP, et al. New coupling agents for the synthesis of immunotoxins containing a hindered disulphide bond with improved stability in vivo. Cancer Res 1987; 47: 5924.
22. Blanchard JM, Pollak R. Techniques for a perfusion and storage of heterotopic heart transplants in mice. Microsurgery 1985; 6: 167.
23. Kruisbeek AM, Titus JA, Stephany DA, Gause BL, Longo DL. In-vivo treatment with monoclonal anti-I-A antibodies: disappearance of splenic antigen-presenting cell function concomitant with modulation of splenic cell surface I-A and I-E antigens. J Immunol 1985; 134: 3605.
24. Qian S, Fu F, Lu, et al. Impact of donor MHC class I or class II antigen deficiency on first and second set rejection of murine heart of liver allografts. Immunology 1996; 88: 124.
25. Lafferty KJ, Prowse SJ, Simeonovic CJ. Immunobiology of tissue transplantation: a return to the passenger leucocyte concept. Annu Rev Immunol 1983; 1: 143.
26. Coulombe M, Yang H, Guerder S, Flavell RA, Lafferty KJ, Gill RG. Tissue immunogenicity: the role of MHC antigen and the lymphocyte co-stimulator B7-1. J Immunol 1996; 157: 4790.
27. Schreiner GF, Flye W, Brient E, Korber K, Lefkowith JB. Essential fatty-acid depletion of renal allografts and prevention of rejection. Science 1988; 240: 1032.
28. McKenzie JL, Beard MEJ, Hart DNJ. The effect of donor pretreatment on interstitial dendritic cell content and rat cardiac allograft survival. Transplantation 1984; 38: 371.
29. Stegall MD, Tezuka K, Oluwole SF, et al. Interstitial class II-positive cell depletion by donor pretreatment with gamma irradiation. Transplantation 1990; 49: 246.
30. Kahn DR, Forrest DE, Otto DA. Prolonged survival of rat cardiac allografts by donor pretreatment with methotrexate. Transplantation 1991; 51: 697.
31. Chen H, Vu D, Wu J, Luo H, Daloze P. Rapamycin graft pretreatment in small-bowel and kidney transplantation in the rat. Transplantation 1995; 59: 1084.
32. Schmidbauer G, Homeyer A, Bohle RM, Grimm H, Binder J, Kupiec-Weglinski JW. Donor pretreatment with methylprednisolone synergistically prolongs survival of cardiac allografts in sensitized rat recipients conditioned with rapamycin. Transplant Proc 1997; 29: 607.
33. Steptoe RJ, Fu F, Lu, et al. Augmentation of dendritic cells in murine organ donors by F1T3 ligand alters the balance between transplant tolerance and immunity. J Immunol 1997; 159: 5483.
34. Goldberg LC, Bradley JA, Connolly J, et al. Anti-CD45 monoclonal antibody perfusion of human renal allografts prior to transplantation. Transplantation 1995; 59: 1285.
35. Pearson TC, Alexander DZ, Winn KJ, Linsley PS, Lowry RP, Larsen CP. Transplantation tolerance induced by CTLA4-Ig. Transplantation 1994; 57: 1701.
36. Pearson TC, Alexander DZ, Corbascio M, et al. Analysis of the B7 co-stimulatory pathway in allograft rejection. Transplantation 1997; 65: 1463.
37. Ramos HC, Reyes J, Abu-Elmagd K, et al. Weaning of immunosuppression in long-term liver transplant recipients. Transplantation 1995; 59: 212.
38. Kupiec-Weglinski JW, Austyn J, Morris PJ. Migration patterns of dendritic cells in the mouse: traffic from blood and T-cell dependent and independent entry to lymphoid tissues. J Exp Med 1988; 167: 632.